Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Vertex Pharmaceuticals Inc. closed 10.29% short of its 52-week high of $519.88, which the company achieved on November 8th.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide ( with these numbers expected to grow. The American Cancer Society ...

Vertex, Inc. (NASDAQ: VERX) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Crivelli - Vice President of Investor Relations David DeStefano - President and Chief ...

MORRISTOWN, N.J., May 07, 2025--Majesco, a global leader in cloud insurance software solutions, is excited to announce a partnership with Vertex Inc., a global provider of indirect tax technology ...

A U.S. Air Force pilot trains on Vertex Solutions’ Gen 2 T-38 enhanced immersive training device at Randolph AFB. Vertex Solutions expands USAF T-38 mixed reality simulator contract, increasing ...

A U.S. Air Force pilot trains on Vertex Solutions’ Gen 2 T-38 enhanced immersive training device at Randolph AFB. Vertex Solutions expands USAF T-38 mixed reality simulator contract, increasing ...

A U.S. Air Force pilot trains on Vertex Solutions’ Gen 2 T-38 enhanced immersive training device at Randolph AFB. Vertex Solutions expands USAF T-38 mixed reality simulator contract, increasing ...

Vertex Solutions’ ITDs are utilized for the U.S. Air Force and Navy’s undergraduate pilot training enterprise, and the firm said they continue to demonstrate measurable performance outcomes.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...